Drug Profile
Phenoxazine
Latest Information Update: 15 Nov 2001
Price :
$50
*
At a glance
- Originator Nonindustrial source
- Class Oxazines; Radiosensitisers
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer
Most Recent Events
- 15 Nov 2001 Discontinued-Preclinical for Cancer in USA (Unknown route)
- 07 Aug 1998 No-Development-Reported for Cancer in USA (Unknown route)
- 16 May 1996 Preclinical development for Cancer in USA (Unknown route)